2025-07-07T14:48:16-05:00 2024-10-31 475284605 ERIC ZHANG & ASSOCIATES LLP 860 HILLVIEW CT STE 230 MILPITAS CA 95035 990PF 2023-11-01 464261053 THE JADE AND HOPE FOUNDATION JADE 4082672890 1788 ROSSWOOD DRIVE SAN JOSE CA 95124 KANGLIE CHIANG CEO 4082672890 2025-07-07 1 1 ERIC ZHANG CPA P00548506 4084358828 2023 2025-03-06 01:10:19Z X 600418 X X 18 18 18 9425 9425 9425 13774 46351 13774 0 23217 23217 9443 0 0 0 0 1386 0 0 1386 569 569 569 0 404 379 379 25 2359 948 948 1411 15000 15000 17359 948 948 16411 5858 22269 8495 821 1523 1523 443337 448493 598895 444158 450016 600418 0 0 X 219638 219638 0 0 224520 230378 444158 450016 444158 450016 444158 5858 0 450016 0 450016 101 SHARES OF GE P 2021-04-27 2024-02-07 13871 7444 6427 6427 0.5622 SHARE OF GEV P 2020-01-28 2024-04-02 79 34 45 45 15827.05 SHARES OF SNVXX P 2023-08-31 2024-07-01 15827 15827 0 0 77 SHARES OF C P 2021-11-26 2024-08-01 4956 5289 -333 -333 28 SHARES OF GE P 2021-04-27 2024-08-01 4865 1693 3172 3172 28 SHARES OF GE P 2020-01-28 2024-08-01 4871 1644 3227 3227 11 SHARES OF GE P 2020-01-28 2024-08-21 1882 646 1236 1236 13774 0 310 0 310 0 310 504 0 0 0 504 0 194 194 0 0 0 0 0 0 0 0 0 0 0 1 1 CA 1 1 0 0 0 1 N/A KANGLIE CHIANG 4082672890 1788 ROSSWOOD DRIVE SAN JOSE CA 95124 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 KANGLIE CHIANG 1788 ROSSWOOD DRIVE SAN JOSE CA 95124 CEO 2.00 0 0 0 GRACE CHINGWEI CHIANG 1788 ROSSWOOD DRIVE SAN JOSE CA 95124 SECRETARY 2.00 0 0 0 KATHY CHINGCHI CHIANG 1788 ROSSWOOD DRIVE SAN JOSE CA 95124 CFO 2.00 0 0 0 NONE 0 NONE 0 SEE STATEMENT 0 0 0 0 0 559870 1931 0 561801 0 0 561801 8427 553374 27669 X 16411 0 16411 X 8495 7770 8273 27239 51777 7221 6605 7032 23153 44010 16411 13365 13383 14303 57462 15000 12000 12000 13000 52000 1411 1365 1383 1303 5462 0 0 18446 15199 15471 18159 67275 0 0 0 0 KANGLIE CHIANG GRACE CHINGWEI CHIANG KATHY CHINGCHI CHIANG X CANCER CAREPOINT INC 2505 SAMARITAN DRIVE BUILDING 400 SUITE 402 SAN JOSE CA 95124 N/A PUBLIC CHARITY DONATION 3000 PANCREATIC CANCER ACTION NETWORK INC 1500 ROSECRANS AVE STE 200 MANHATTAN BEACH CA 90266 N/A PUBLIC CHARITY DONATION 2000 UCSF FOUNDATION UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA 94143 N/A PUBLIC CHARITY DONATION 10000 15000 0 14 18 14 9425 18 13774 0 23217 0 23217 0 0 0 0 0 0 0 0 0 0 TAX PREPARATION FEE 1386 0 0 1386 SUMMARY OF CHARTIABLE ACTIVITIES FORM 990 PF, PART VIII-A IN 2024, THE JADE AND HOPE FOUNDATION CONTINUED ITS UNWAVERING SUPPORT FOR PANCREATIC CANCER RESEARCH AT THE HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER AT THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (UCSF). OUR MISSION REMAINS FIRMLY ROOTED IN IMPROVING THE QUALITY OF LIFE AND EXPANDING TREATMENT OPTIONS FOR THOSE BATTLING THIS DEVASTATING DISEASE.PANCREATIC CANCER REMAINS ONE OF THE MOST FORMIDABLE AND UNDER-RESEARCHED CANCERS, OFTEN DIAG-NOSED AT AN ADVANCED STAGE WITH LIMITED THERAPEUTIC OPTIONS. "PANCREATIC CANCER IS AN INCREDIBLY CHALLENGING DISEASE, AND ONE IN WHICH WE'VE MADE DISTRESSINGLY LITTLE PROGRESS," SAID DR. ALAN ASHWORTH OF UCSF. "MORE OFTEN THAN NOT, WE DIAGNOSE IT IN ADVANCED STAGES, LEAVING US WITH VERY FEW TREATMENT OPTIONS. LARGE NATIONAL TRIALS THAT OFFER PATIENTS REAL-TIME ALTERNATIVES DURING THEIR CARE REPRESENT A NEW AND PROMISING MODELAND THAT'S HOW WE'LL BEGIN TO MAKE PROGRESS AGAINST A CANCER AS FORMIDABLE AS PANCREATIC."UCSF'S LEADERSHIP IN CLINICAL TRIAL DESIGN, GENOMICS, IMMUNOTHERAPY, AND DNA REPAIR MAKES IT AN IDEAL PARTNER FOR A GROUNDBREAKING, MULTI-YEAR CLINICAL STUDY. THIS STUDY WILL EXPLORE MULTIPLE THERAPEUTIC STRATEGIESKNOWN AS SUB-STUDIESWITHIN A SINGLE, ADAPTIVE TRIAL FRAMEWORK. EACH SUB-STUDY IS TAILORED TO THE PATIENT'S UNIQUE MOLECULAR AND TUMOR PROFILE, ENABLING A PERSONALIZED APPROACH TO TREATMENT. IMPORTANTLY, THE TRIAL'S DESIGN ALLOWS PATIENTS TO SWITCH TO OTHER OPTIONS IF THEIR CANCER FAILS TO RESPOND, OFFERING RENEWED HOPE AND FLEXIBILITY IN CARE.OUR FOUNDATION'S ONGOING SUPPORT ALSO REFLECTS UCSF'S BROADER MISSION TO EDUCATE THE NEXT GEN-ERATION OF SCIENTISTS AND CLINICIANS WHILE ADDRESSING TODAY'S MOST URGENT BIOMEDICAL CHALLENGES. THROUGH OUR CONTRIBUTIONS, WE AIM TO ADVANCE PERSONALIZED MEDICINEMAXIMIZING THERAPEUTIC EFFECTIVENESS AND MINIMIZING SIDE EFFECTS. UCSF'S CUTTING-EDGE WORK IN TARGETED THERAPIES, CAN-CER GENOMICS, AI-DRIVEN PRECISION ONCOLOGY, AND EARLY DETECTION OF DIFFICULT-TO-TREAT CANCERS EX-EMPLIFIES THE INNOVATION WE ARE PROUD TO CHAMPION.IN ADDITION TO OUR PARTNERSHIP WITH UCSF, THE JADE AND HOPE FOUNDATION IS PROUD TO SUPPORT THE IMPACTFUL WORK OF THE PANCREATIC CANCER ACTION NETWORK (PANCAN). OUR CONTRIBUTIONS HAVE HELPED ADVANCE PANCAN'S MISSION TO PROVIDE PATIENTS WITH CRITICAL RESOURCESINCLUDING ACCESS TO CLINICAL TRIALS, COMPREHENSIVE INFORMATION, AND PERSONALIZED GUIDANCE THROUGH DEDICATED CASE MANAGERS.WHEN PANCAN LAUNCHED ITS GROUNDBREAKING KNOW YOUR TUMOR PRECISION MEDICINE INITIATIVE IN 2014, THERE WAS STILL UNCERTAINTY ABOUT THE ROLE OF GENETIC AND BIOMARKER TESTING IN TREATING PAN-CREATIC CANCER. A DECADE LATER, THE RESULTS SPEAK FOR THEMSELVES. THANKS TO THE SUPPORT OF VISION-ARY DONORS, THIS PERSONALIZED APPROACH HAS PROVEN SO EFFECTIVE THAT IT IS NOW RECOMMENDED IN NA-TIONAL PANCREATIC CANCER TREATMENT GUIDELINES AND INCREASINGLY COVERED BY INSURANCEUNLOCKING ACCESS TO PRECISION MEDICINE FOR MORE PATIENTS TODAY AND IN THE FUTURE.WE ARE ALSO PROUD TO SUPPORT PANCAN'S PRECISION PROMISE ADAPTIVE CLINICAL TRIAL PLATFORM, LAUNCHED IN 2020 TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS. TRADITIONAL TRIAL MODELS WERE SLOW AND INEFFICIENT FOR A DISEASE AS AGGRESSIVE AS PANCREATIC CANCER. IN CONTRAST, PRECISION PROM-ISE ENABLES FASTER, MORE FLEXIBLE EVALUATION OF POTENTIAL THERAPIES BY REQUIRING FEWER PATIENTS AND ALLOWING MULTIPLE INVESTIGATIONAL TREATMENTS TO BE TESTED SIMULTANEOUSLY.BY STAYING ACTIVELY ENGAGED WITH PANCAN'S SEMINARS AND RESEARCH PUBLICATIONS, WE REMAIN IN-FORMED OF THE LATEST ADVANCES IN PANCREATIC CANCER CARE AND CONTINUE TO ALIGN OUR SUPPORT WITH THE MOST PROMISING INNOVATIONSIN ADDITION TO OUR EFFORTS IN RESEARCH AND ADVOCACY, OUR FOUNDATION REMAINS DEEPLY DEDICATED TO SUPPORTING LOCAL CANCER PATIENTS AND THEIR FAMILIES IN THE SAN JOSE, CALIFORNIA AREA THROUGH OUR CONTRIBUTIONS TO CANCER CAREPOINT. CANCER CAREPOINT PROVIDES PERSONALIZED COUNSELING, AS-SISTANCE, RESOURCES & EDUCATION TO BAY AREA CANCER PATIENTS, SURVIVORS, FAMILIES & CAREGIVERS AT NO COST.THIS OUTSTANDING ORGANIZATION PROVIDES A COMPREHENSIVE RANGE OF VITAL SERVICES DESIGNED TO MEET THE DIVERSE AND EVOLVING NEEDS OF BOTH PATIENTS AND CAREGIVERS, INCLUDING: PERSONALIZED COUNSELING AND FAMILY SUPPORT EXERCISE AND MOVEMENT PROGRAMS MIND-BODY WELLNESS TECHNIQUES NUTRITION EDUCATION AND SERVICES PEER-LED SUPPORT GROUPSIN SUMMARY, THE JADE AND HOPE FOUNDATION REAFFIRMED ITS DEEP COMMITMENT TO IMPROVING THE LIVES OF PANCREATIC CANCER PATIENTS THROUGH SUSTAINED SUPPORT OF LEADING RESEARCH AND PATIENT SER-VICES. PARTNERING WITH UCSF'S HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER, THE FOUNDA-TION BACKED INNOVATIVE, PERSONALIZED CLINICAL TRIALS AIMED AT TACKLING ONE OF THE MOST AGGRESSIVE AND UNDER-RESEARCHED CANCERS. IT ALSO CONTINUED ITS SUPPORT OF THE PANCREATIC CANCER ACTION NETWORK (PANCAN), HELPING EXPAND ACCESS TO PRECISION MEDICINE AND ACCELERATE THE DEVELOP-MENT OF NEW THERAPIES THROUGH ADAPTIVE CLINICAL TRIALS. LOCALLY, THE FOUNDATION REMAINED DEVOTED TO SERVING CANCER PATIENTS AND THEIR FAMILIES IN SAN JOSE THROUGH CONTRIBUTIONS TO CANCER CARE-POINT, WHICH OFFERS VITAL SUPPORT SERVICES INCLUDING COUNSELING, NUTRITION, EXERCISE, AND WELLNESS PROGRAMS. THESE EFFORTS REFLECT THE FOUNDATION'S HOLISTIC APPROACH TO ADVANCING CANCER CARE, FROM CUTTING-EDGE RESEARCH TO COMPASSIONATE COMMUNITY SUPPORT. INVESTMENT STOCKS FROM CHARLES SCHWAB 448493 598895 FILLING FEE 25 0 0 25 INVESTMENT EXPENSE 379 379 379 0 FOREIGN TAX 569 569 569 0